These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10958867

  • 1. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy.
    Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A.
    Clin Chim Acta; 2000 Oct; 300(1-2):107-17. PubMed ID: 10958867
    [Abstract] [Full Text] [Related]

  • 2. Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: effect of methimazole treatment.
    Bednarek J, Wysocki H, Sowinski J.
    Free Radic Res; 2004 Jun; 38(6):659-64. PubMed ID: 15346657
    [Abstract] [Full Text] [Related]

  • 3. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J, Wysocki H, Sowiński J.
    Immunol Lett; 2004 May 15; 93(2-3):227-32. PubMed ID: 15158621
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
    Bednarek J, Wysocki H, Sowiński J.
    Clin Biochem; 2005 Jan 15; 38(1):13-8. PubMed ID: 15607311
    [Abstract] [Full Text] [Related]

  • 5. Evidence for carbimazole as an antioxidant?
    Wilson R, Buchanan L, Fraser WD, Jenkins C, Smith WE, Reglinski J, Thomson JA, McKillop JH.
    Autoimmunity; 1998 Jan 15; 27(3):149-53. PubMed ID: 9609132
    [Abstract] [Full Text] [Related]

  • 6. Antioxidant activity and structural modifications of serum chondroitin sulfate in Graves' disease.
    Winsz-Szczotka K, Komosińska-Vassev K, Kuźnik-Trocha K, Olczyk K.
    Clin Biochem; 2014 Jan 15; 47(1-2):19-24. PubMed ID: 23954851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.
    Komosińska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K.
    Diabetes Res Clin Pract; 2005 Jun 15; 68(3):207-16. PubMed ID: 15936462
    [Abstract] [Full Text] [Related]

  • 10. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism.
    Rybus-Kalinowska B, Zwirska-Korczala K, Kalinowski M, Kukla M, Birkner E, Jochem J.
    Pol Arch Med Wewn; 2008 Jun 15; 118(7-8):420-5. PubMed ID: 18714737
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K.
    J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Effect of Immunosuppression on Selected Antioxidant Parameters in Patients with Graves' Disease with Active Thyroid-Associated Orbitopathy.
    Londzin-Olesik M, Kos-Kudla B, Karpe J, Nowak A, Nowak M.
    Exp Clin Endocrinol Diabetes; 2021 Oct 06; 129(10):762-769. PubMed ID: 33157557
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M, Siemińska L, Karpe J, Marek B, Kos-Kudła B, Kajdaniuk D.
    J Endocrinol Invest; 2016 Jan 06; 39(1):63-72. PubMed ID: 26062519
    [Abstract] [Full Text] [Related]

  • 16. Free radicals and Graves' disease: the effects of therapy.
    Wilson R, Chopra M, Bradley H, McKillop JH, Smith WE, Thomson JA.
    Clin Endocrinol (Oxf); 1989 Apr 06; 30(4):429-33. PubMed ID: 2598476
    [Abstract] [Full Text] [Related]

  • 17. The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease.
    Bacic-Vrca V, Skreb F, Cepelak I, Mayer L, Kusic Z, Petres B.
    Clin Chem Lab Med; 2005 Apr 06; 43(4):383-8. PubMed ID: 15899653
    [Abstract] [Full Text] [Related]

  • 18. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
    Hondur A, Konuk O, Dincel AS, Bilgihan A, Unal M, Hasanreisoglu B.
    Curr Eye Res; 2008 May 06; 33(5):421-7. PubMed ID: 18568878
    [Abstract] [Full Text] [Related]

  • 19. [Free radical concepts in the etiopathogenesis of Graves-Basedow disease].
    Komosińska-Vassev K, Olczyk K, Winsz K.
    Postepy Hig Med Dosw; 2000 May 06; 54(2):225-37. PubMed ID: 10857382
    [Abstract] [Full Text] [Related]

  • 20. Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles.
    Lutosławska G, Tkaczyk J, Panczenko-Kresowska B, Hübner-Woźniak E, Skierska E, Gajewski AK.
    Clin Chim Acta; 2003 May 06; 331(1-2):159-63. PubMed ID: 12691877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.